Polyphor Launches Development of Inhaled Antibiotic for Respiratory Diseases
News
Polyphor, a Swiss specialty pharmaceutical company, is launching the development of an inhaled form of the investigational antibiotic murepavadin (POL7080). Murepavadin, a type of outer membrane protein targeting antibiotic (OMPTA), ... Read more